S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

VIRX Viracta Therapeutics Inc

0.800001

-0.0196 (-2.39%)

Last Updated: 23:55:01

Delayed by 15 minutes

Xoma is on course for a multi-year high

To read the full story on Seeking Alpha, click here.

Viracta Therapeutics (NASDAQ:VIRX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Viracta Therapeutics Charts.

Viracta Therapeutics (NASDAQ:VIRX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Viracta Therapeutics Charts.

Viracta Therapeutics Inc News

Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma
Monday 15 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.

Viracta Therapeutics Announces Completion of Second-Stage Enrollment into the Peripheral T-Cell Lymphoma Cohort of the NAVAL-1 Trial
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Wednesday 7 February 2024 (3 months ago) • GlobeNewswire Inc.

More Viracta Therapeutics Inc News Articles

Verizon Communications

Gold vs US Dollar

Newcrest Mining

Invesco QQQ Trust Series 1

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions